The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge manufacturing capabilities, and a highly skilled workforce.

The changing nature of Markets is one of most ... D and in driving new collaborations and consolidation in the pharmaceutical industry. For example, in 2009 Pfizer acquired Wyeth, maker of largest ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

The rise of LSHC GCCs in India is driven by the country’s vast technology talent pool, cost efficiencies, and a dynamic business environment fostering research, innovation, and operational excellence.

India is increasingly making a mark in the global pharmaceutical Contract Development ... are shifting production to India, signaling a changing global landscape. "Many multinational firms are ...

Indian pharmaceutical CDMOs are anticipated to encounter minimal disruptions from the proposed US tariffs of 10-25 per cent.

PRIP Scheme to Foster Affordable Healthcare Innovation in India - The Government of Indias Department of Pharmaceuticals organized an industry forum in Mumbai ...

Union Minister of Commerce and Industry Piyush ... hub and hosts India’s largest pharma clusters and biotech research centres. These have been a catalyst of change expanding global healthcare ...